Introduction to new Pharmacogenomics Program PREDICT on Sept. 1
The Vanderbilt Institute for Clinical and Translational Research (VICTR) is sponsoring a session to introduce PREDICT, a Vanderbilt program that will use pharmacogenomics to affect the future of personalized medicine.
This event will take place from 1-2 p.m. on Wednesday, Sept. 1, in 202 Light Hall.
Speakers introducing PREDICT, which stands for Pharmacogenomic Resource for Enhanced Decisions in Care and Treatment, will be Dan Roden, M.D., assistant vice chancellor for Personalized Medicine, and Jim Jirjis, M.D., MBA, assistant chief medical officer.
All faculty, staff and students are invited to attend. Lunch will be provided. To make a reservation, please e-mail firstname.lastname@example.org.